APC Microbiome Institute, University College Cork, Cork, Ireland.
Department of Psychiatry and Neurobehavioural Sciences, University College Cork, Cork, Ireland.
Ann N Y Acad Sci. 2018 May;1420(1):5-25. doi: 10.1111/nyas.13416. Epub 2017 Aug 2.
There is a growing appreciation of the role of the gut microbiota in all aspects of health and disease, including brain health. Indeed, roles for the bacterial commensals in various psychiatric and neurological conditions, such as depression, autism, stroke, Parkinson's disease, and Alzheimer's disease, are emerging. Microbiota dysregulation has been documented in all of these conditions or in animal models thereof. Moreover, depletion or modulation of the gut microbiota can affect the severity of the central pathology or behavioral deficits observed in a variety of brain disorders. However, the mechanisms underlying such effects are only slowly being unraveled. Additionally, recent preclinical and clinical evidence suggest that targeting the microbiota through prebiotic, probiotic, or dietary interventions may be an effective "psychobiotic" strategy for treating symptoms in mood, neurodevelopmental disorders, and neurodegenerative diseases.
人们越来越意识到肠道微生物群在健康和疾病的各个方面的作用,包括大脑健康。事实上,细菌共生体在各种精神和神经疾病中的作用正在显现,如抑郁症、自闭症、中风、帕金森病和阿尔茨海默病。在所有这些疾病或其动物模型中都有记录到微生物群失调。此外,肠道微生物群的耗竭或调节会影响各种脑部疾病中观察到的中枢病理或行为缺陷的严重程度。然而,这些影响的机制只是在慢慢被揭示。此外,最近的临床前和临床证据表明,通过使用益生元、益生菌或饮食干预来靶向微生物群可能是一种有效的“精神益生菌”策略,可以治疗情绪、神经发育障碍和神经退行性疾病的症状。